Science Explorer Back to mapMap
Discussion
Company · Lexington · United States

ImmuneXcite (United States)

immunexcite.comROR OpenAlex
Research works
2
fractional, all time
Citations
0
0.0 per fractional work
Top-10% rate
6.0%
all institutions 10.0%
Open access
80%
world 40%
ImmuneXcite (United States)

Not ranked overall: ImmuneXcite (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does ImmuneXcite (United States) work in?

In all years, 54% of research at ImmuneXcite (United States) is in Life Sciences, 27% in Health Sciences. Its largest fields are Immunology and Microbiology (46%), Medicine (27%), Engineering (19%). It does 1.3× the world's share of Life Sciences.

Life Sciences: 1 fractional works · 53.8% of its workImmunology and Microbiology: 1 fractional works · 46.2% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 7.7% of its workHealth Sciences: 1 fractional works · 26.9% of its workMedicine: 1 fractional works · 26.9% of its workPhysical Sciences: 0 fractional works · 19.2% of its workEngineering: 0 fractional works · 19.2% of its workALL ITS WORKImmuneXcite(United States)3fractional works, all years
Life Sciences54%Physical Sciences19%Health Sciences27%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 4 fields, with their numbers
    1. Immunology and Microbiology146.2%
    2. Biochemistry, Genetics and Molecular Biology07.7%
    1. Medicine126.9%
    1. Engineering019.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Which research topics does ImmuneXcite (United States) publish most on?

By volume: Immune cells in cancer, Cancer Immunotherapy and Biomarkers, Nanoplatforms for cancer theranostics and Immunotherapy and Immune Responses.

Immune cells in cancer1Immune cells in cancer: 1 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksNanoplatforms for cancer theranostics: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksCancer Research and Treatments: 0 fractional works
ImmunologyOncologyBiomedical EngineeringBiotechnology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immune cells in cancer Immunology 1 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 1 works
  3. 3 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  4. 4 Immunotherapy and Immune Responses Immunology 0 works
  5. 5 Cancer Research and Treatments Biotechnology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available80.0%not open20.0%

World: 40% of research is openly available.

Other research institutions in Lexington

All research institutions in Lexington

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ImmuneXcite (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.